Eye & Ear SpecialtyEye & Ear Care
Antibiotic eye/ear drops, artificial tears, glaucoma drops, and lubricating gels.
Formulation & Pricing Breakdown46 pricedView details
Therapeutic Subcategories (5)
Select a specialized division to filter formulations by clinical indication
All Formulations in Eye & Ear Care (58)
Find Nearby KendraCarboxymethylcellulose Sodium Eye Drops 0.5% w/v
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Ciprofloxacin Eye Drops 0.3% w/v
Ciprofloxacin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Gentamicin Eye Drops 0.3% w/v
Gentamicin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Timolol Maleate Eye Drops 0.5 %
Timolol Maleate (0.5% w/v) is a non-selective beta-1 and beta-2 adrenergic receptor antagonist on the WHO Model List of Essential Medicines. It blocks beta-adrenergic receptors on non-pigmented ciliary epithelial cells, inhibiting cyclic AMP synthesis and reducing aqueous humor secretion by 30-50% without altering pupillary size or accommodation. Indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma and ocular hypertension.
Ofloxacin Eye Drops 0.3% w/v
Ofloxacin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v
Olopatadine Hydrochloride (0.1%, 0.2% w/v) is a dual-action mast cell stabilizer and selective histamine H1 receptor antagonist on the WHO Model List of Essential Medicines. It blocks H1 receptors on conjunctival nerves and vascular endothelium (providing rapid relief of itching within 30 minutes) and stabilizes mast cell membranes, inhibiting histamine, tryptase, and leukotriene degranulation. Indicated for the treatment of signs and symptoms of allergic conjunctivitis (seasonal and perennial).
Tropicamide Eye Drops 1% W/V
Parasympatholytic Mydriatic and Cycloplegic agent on the WHO Model List of Essential Medicines. It competitively blocks muscarinic acetylcholine receptors in the eye, paralyzing the pupillary sphincter muscle (causing mydriasis / pupil dilation) and the ciliary muscle (causing cycloplegia / paralysis of accommodation). Indicated for diagnostic mydriasis and cycloplegic refraction, and for preventing posterior synechiae in acute anterior uveitis.
Polymyxin B Sulphate 5000IU + Chloramphenicol 4mg + Dexamethasone 1mg Eye/Ear Drops
Ceruminolytic Ear Drop formulation combining Paradichlorobenzene (2%), Chlorbutol (5%), Turpentine Oil (15%), and Lidocaine (2%). Paradichlorobenzene hydrates and dissolves hard impacted cerumen; turpentine oil acts as a counter-irritant and cerumen liquefier; chlorbutol provides mild antibacterial and antifungal preservation; and lidocaine relieves localized ear canal pain and tension. Indicated for softening, loosening, and removal of hardened, impacted ear wax.
Sulphacetamide Eye Drop 10 % w/v
Sulphacetamide Eye Drop 10 % w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Acyclovir Eye Ointment 3% W/W
Acyclovir (3% w/w ophthalmic ointment) is a synthetic purine nucleoside analogue antiviral on the WHO Model List of Essential Medicines. It is selectively converted by viral thymidine kinase into acyclovir monophosphate, which is subsequently converted to triphosphate, competitively inhibiting herpes simplex DNA polymerase and halting viral replication. Indicated for the treatment of herpes simplex keratitis (dendritic corneal ulcers).
Pilocarpine Eye Drops 2% W/V
Pilocarpine Hydrochloride (2% w/v eye drops) is a direct parasympathomimetic (cholinergic) miotic agent on the WHO Model List of Essential Medicines. It stimulates muscarinic receptors on the pupillary sphincter muscle (causing miosis) and the ciliary muscle (causing contraction that pulls the scleral spur and opens the trabecular meshwork), facilitating aqueous outflow. Indicated for acute angle-closure glaucoma emergency management, chronic open-angle glaucoma, and reversal of mydriasis.
Bromfenac Sodium Eye Drop 0.09%w/v
Bromfenac Sodium (0.09% w/v eye drops) is a potent brominated ophthalmic NSAID. Bromination confers high lipophilicity, allowing rapid corneal penetration and prolonged inhibition of cyclooxygenase-2 (COX-2) in iris, ciliary body, and retina, providing sustained 24-hour relief of ocular pain and inflammation with once- or twice-daily dosing. Indicated for post-operative ocular inflammation and pain following cataract surgery.
Chloramphenicol Eye Ointment 1%w/w
Chloramphenicol Eye Ointment 1%w/w is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Nepafenac Eye Drop 0.1% W/V
Nepafenac (0.1% w/v eye drops) is an ophthalmic non-steroidal anti-inflammatory prodrug. It penetrates the cornea rapidly, where intraocular hydrolases convert it into amfenac, a potent cyclooxygenase (COX-1 and COX-2) inhibitor, suppressing prostaglandin synthesis in the anterior and posterior chambers. Indicated for the prevention and treatment of post-operative ocular pain and inflammation, and reduction in the risk of macular edema associated with cataract surgery in diabetic patients.
Moxifloxacin Hydrochloride Eye Drops 0.5% w/v
Moxifloxacin Hydrochloride (0.5% w/v ophthalmic solution) is a fourth-generation fluoroquinolone broad-spectrum bactericidal eye drop on the WHO Model List of Essential Medicines. It simultaneously inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, demonstrating high corneal tissue penetration, low resistance rates, and exceptional potency against Streptococcus pneumoniae, Staphylococcus aureus (including MRSA), and Gram-negative ocular pathogens. Self-preserved formulation eliminates the need for epithelial-toxic preservatives like benzalkonium chloride. Indicated for bacterial conjunctivitis and peri-operative prophylaxis in intraocular surgeries.
Tobramycin Eye Drops 0.3%w/v
Tobramycin (0.3% w/v eye drops) is a water-soluble aminoglycoside bactericidal antibiotic. It binds to the 30S ribosomal subunit, disrupting protein synthesis. Exhibits potent bactericidal activity against Pseudomonas aeruginosa, Proteus, and staphylococci. Indicated for external bacterial infections of the eye and surrounding adnexa (blepharitis, conjunctivitis, keratitis).
Bimatoprost Ophthalmic Solution 0.01% w/v
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Bimatoprost Ophthalmic Solution 0.03% w/v
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Brimonidine Tartrate 0.2%w/v + Timolol Maleate 0.5%w/v Ophthalmic Solution
Timolol Maleate (0.5% w/v) is a non-selective beta-1 and beta-2 adrenergic receptor antagonist on the WHO Model List of Essential Medicines. It blocks beta-adrenergic receptors on non-pigmented ciliary epithelial cells, inhibiting cyclic AMP synthesis and reducing aqueous humor secretion by 30-50% without altering pupillary size or accommodation. Indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma and ocular hypertension.
Brimonidine Tartrate Eye drops 0.1% w/v
Brimonidine Tartrate (0.1%, 0.2% w/v, alone or with Timolol/Brinzolamide) is a highly selective alpha-2 adrenergic receptor agonist on the WHO Model List of Essential Medicines. It exerts a dual mechanism: reducing aqueous humor production via alpha-2-mediated adenylyl cyclase inhibition in ciliary epithelium, and stimulating uveoscleral aqueous humor outflow via prostaglandin release. Also demonstrates retinal ganglion cell neuroprotective properties. Indicated for lowering intraocular pressure in open-angle glaucoma and ocular hypertension.
Carboxymethlycellulose Eye drops 1% w/v
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Dorzolamide 2% w/v + Timolol 0.5% w/v Eye Drops
Timolol Maleate (0.5% w/v) is a non-selective beta-1 and beta-2 adrenergic receptor antagonist on the WHO Model List of Essential Medicines. It blocks beta-adrenergic receptors on non-pigmented ciliary epithelial cells, inhibiting cyclic AMP synthesis and reducing aqueous humor secretion by 30-50% without altering pupillary size or accommodation. Indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma and ocular hypertension.
Dorzolamide Eye Drops 2% w/v
Topical Carbonic Anhydrase Inhibitor (Dorzolamide 2% or Brinzolamide 1% suspension, alone or with Timolol) on the WHO Model List of Essential Medicines. It inhibits carbonic anhydrase II (CA-II) in the ciliary processes, slowing bicarbonate ion formation and reducing active sodium and fluid transport, thereby diminishing aqueous humor secretion by up to 20-30%. Indicated for intraocular pressure reduction in open-angle glaucoma and ocular hypertension.
Hydroxypropylmethylcellulose Eye Drop 0.3% w/v
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Travoprost Ophthalmic Solution 0.004%w/v
Travoprost (0.004% w/v, alone or with Timolol 0.5%) is a synthetic prostaglandin F2-alpha analogue and full selective FP prostanoid receptor agonist on the WHO Model List of Essential Medicines. It significantly enhances uveoscleral aqueous outflow. Indicated for lowering intraocular pressure in open-angle glaucoma and ocular hypertension.
Azithromycin Eye Drops 1% w/v
Azithromycin Eye Drops 1% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Betaxolol Eye Drops 0.5% w/v
Betaxolol Eye Drops 0.5% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Brinzolamide Ophthalmic Suspension 1% w/v
Topical Carbonic Anhydrase Inhibitor (Dorzolamide 2% or Brinzolamide 1% suspension, alone or with Timolol) on the WHO Model List of Essential Medicines. It inhibits carbonic anhydrase II (CA-II) in the ciliary processes, slowing bicarbonate ion formation and reducing active sodium and fluid transport, thereby diminishing aqueous humor secretion by up to 20-30%. Indicated for intraocular pressure reduction in open-angle glaucoma and ocular hypertension.
Bromfenac 0.09% w/v + Moxifloxacin 0.5% w/v Eye Drops
Moxifloxacin and NSAID (Bromfenac 0.09% or Ketorolac 0.5%) ophthalmic solution is an antibacterial and non-steroidal anti-inflammatory combination. Moxifloxacin provides broad bactericidal coverage, while the ophthalmic NSAID inhibits cyclooxygenase (COX-1/COX-2) enzymes to block prostaglandin synthesis, relieving ocular pain, photophobia, and anterior chamber flare without the intraocular pressure spikes or cataract risks associated with steroids. Indicated for post-cataract surgery ocular pain, inflammation, and infection prophylaxis.
Chloramphenicol 0.5% w/v + Dexamethasone 0.1% w/v Eye/Ear Drops
Ceruminolytic Ear Drop formulation combining Paradichlorobenzene (2%), Chlorbutol (5%), Turpentine Oil (15%), and Lidocaine (2%). Paradichlorobenzene hydrates and dissolves hard impacted cerumen; turpentine oil acts as a counter-irritant and cerumen liquefier; chlorbutol provides mild antibacterial and antifungal preservation; and lidocaine relieves localized ear canal pain and tension. Indicated for softening, loosening, and removal of hardened, impacted ear wax.
Gatifloxacin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops
Gatifloxacin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Gatifloxacin 0.3 % w/v + Prednisolone 1% w/v Eye Drops
Prednisolone Acetate / Sodium Phosphate (1% w/v eye drops) is the gold-standard topical ophthalmic corticosteroid on the WHO Model List of Essential Medicines. It delivers high corneal and intraocular penetration, suppressing cellular infiltration, capillary dilatation, fibroblast proliferation, and collagen deposition in the anterior segment. Indicated for steroid-responsive ocular inflammation (anterior uveitis, post-operative cataract inflammation, severe allergic blepharoconjunctivitis, and corneal graft rejection prophylaxis).
Gentamicin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops
Gentamicin 0.3% w/v + Dexamethasone 0.1% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Homatropine Hydrobromide Eye Drops 2% w/v
Parasympatholytic Mydriatic and Cycloplegic agent on the WHO Model List of Essential Medicines. It competitively blocks muscarinic acetylcholine receptors in the eye, paralyzing the pupillary sphincter muscle (causing mydriasis / pupil dilation) and the ciliary muscle (causing cycloplegia / paralysis of accommodation). Indicated for diagnostic mydriasis and cycloplegic refraction, and for preventing posterior synechiae in acute anterior uveitis.
Levofloxacin Eye Drops 0.5 % w/v
Levofloxacin Eye Drops 0.5 % w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Moxifloxacin 0.5% w/v + Dexamethasone 0.1% w/v Eye Drops
Moxifloxacin and Corticosteroid (Dexamethasone 0.1% or Prednisolone 1%) ophthalmic drops is a broad-spectrum anti-infective and potent anti-inflammatory combination. Moxifloxacin (0.5%), a 4th-generation fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV across Gram-positive, Gram-negative, and atypical pathogens, while the steroid suppresses ocular surgical trauma, anterior chamber inflammation, and corneal edema. Indicated for post-operative prevention and treatment of inflammation and infection following cataract, refractive, or vitreoretinal surgery.
Natamycin Ophthalmic Suspension 5% w/v
Natamycin (5% w/v ophthalmic suspension) is a tetraene polyene broad-spectrum fungicidal antibiotic on the WHO Model List of Essential Medicines. It is the premier drug of choice for fungal keratitis. It binds selectively to fungal cell membrane ergosterol, disrupting membrane permeability and causing lethal leakage of essential ions and macromolecules. Highly active against filamentous fungi (Fusarium, Aspergillus, Curvularia) and yeasts (Candida). Indicated for fungal blepharitis, conjunctivitis, and fungal keratitis.
Bacitracin 400 IU + Neomycin 3400 IU + Polymyxin B 5000 IU Opthalmic Ointment
Bacitracin 400 IU + Neomycin 3400 IU + Polymyxin B 5000 IU Opthalmic Ointment is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Bimatoprost 0.03% w/v + Timolol 0.5% w/v Ophthalmic Solution
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Sodium Hyaluronate Eye Drops 0.1% w/v
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Ofloxacin 0.3% w/v + Dexamethasone 0.1% w/v + Benzalkonium Chloride (As Preservative) 0.005% w/v Eye Drops
Ofloxacin 0.3% w/v + Dexamethasone 0.1% w/v + Benzalkonium Chloride (As Preservative) 0.005% w/v Eye Drops is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Clotrimazole 1% w/v + Lignocaine Hydrochloride 2% w/v Ear Drops
Clotrimazole and Lignocaine Hydrochloride ear drops is an antifungal and local anesthetic otic combination. Clotrimazole (1% w/v) disrupts fungal cell membrane permeability, eradicating Aspergillus niger and Candida species responsible for otomycosis, while lignocaine (2% w/v) reversibly blocks neuronal sodium channels, providing rapid relief of severe deep ear pain and pruritus. Indicated for fungal otitis externa (otomycosis) accompanied by pain and inflammation.
Prednisolone Sodium Phosphate Eye Drops 1%w/v
Prednisolone Acetate / Sodium Phosphate (1% w/v eye drops) is the gold-standard topical ophthalmic corticosteroid on the WHO Model List of Essential Medicines. It delivers high corneal and intraocular penetration, suppressing cellular infiltration, capillary dilatation, fibroblast proliferation, and collagen deposition in the anterior segment. Indicated for steroid-responsive ocular inflammation (anterior uveitis, post-operative cataract inflammation, severe allergic blepharoconjunctivitis, and corneal graft rejection prophylaxis).
Moxifloxacin 0.5 %w/v + Prednisolone Acetate 1%w/v Eye Drops
Moxifloxacin and Corticosteroid (Dexamethasone 0.1% or Prednisolone 1%) ophthalmic drops is a broad-spectrum anti-infective and potent anti-inflammatory combination. Moxifloxacin (0.5%), a 4th-generation fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV across Gram-positive, Gram-negative, and atypical pathogens, while the steroid suppresses ocular surgical trauma, anterior chamber inflammation, and corneal edema. Indicated for post-operative prevention and treatment of inflammation and infection following cataract, refractive, or vitreoretinal surgery.
Brinzolamide 10mg + Brimonidine 2mg Ophthalmic Suspension 5ml
Brimonidine Tartrate (0.1%, 0.2% w/v, alone or with Timolol/Brinzolamide) is a highly selective alpha-2 adrenergic receptor agonist on the WHO Model List of Essential Medicines. It exerts a dual mechanism: reducing aqueous humor production via alpha-2-mediated adenylyl cyclase inhibition in ciliary epithelium, and stimulating uveoscleral aqueous humor outflow via prostaglandin release. Also demonstrates retinal ganglion cell neuroprotective properties. Indicated for lowering intraocular pressure in open-angle glaucoma and ocular hypertension.
Paradichlorobenzene (2% w/v) + Chlorbutol (5% w/v) + Turpentine Oil (15% w/v) + Lidocaine (2% w/v) Ear drop
Ceruminolytic Ear Drop formulation combining Paradichlorobenzene (2%), Chlorbutol (5%), Turpentine Oil (15%), and Lidocaine (2%). Paradichlorobenzene hydrates and dissolves hard impacted cerumen; turpentine oil acts as a counter-irritant and cerumen liquefier; chlorbutol provides mild antibacterial and antifungal preservation; and lidocaine relieves localized ear canal pain and tension. Indicated for softening, loosening, and removal of hardened, impacted ear wax.
Flurbiprofen 0.03% w/v Eye Drop 5ml
Flurbiprofen 0.03% w/v Eye Drop 5ml is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.
Fluromethalone 0.1% w/v Eye Drop 5ml
Fluorometholone (0.1% w/v ophthalmic suspension) is a surface-active fluorinated synthetic topical corticosteroid. It undergoes rapid enzymatic metabolism in the anterior chamber, conferring robust anti-inflammatory relief of conjunctival and superficial corneal inflammation while possessing significantly lower propensity to elevate intraocular pressure than dexamethasone or prednisolone. Indicated for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment.
Ketorolac (0.5% W/V) + Moxifloxacin (0.5% W/V) Eye Drops
Moxifloxacin and NSAID (Bromfenac 0.09% or Ketorolac 0.5%) ophthalmic solution is an antibacterial and non-steroidal anti-inflammatory combination. Moxifloxacin provides broad bactericidal coverage, while the ophthalmic NSAID inhibits cyclooxygenase (COX-1/COX-2) enzymes to block prostaglandin synthesis, relieving ocular pain, photophobia, and anterior chamber flare without the intraocular pressure spikes or cataract risks associated with steroids. Indicated for post-cataract surgery ocular pain, inflammation, and infection prophylaxis.
Olopatadine Hydrochloride 0.4% w/v + Ketorolac 0.1 % w/v Ophthalmic Solution
Olopatadine Hydrochloride (0.1%, 0.2% w/v) is a dual-action mast cell stabilizer and selective histamine H1 receptor antagonist on the WHO Model List of Essential Medicines. It blocks H1 receptors on conjunctival nerves and vascular endothelium (providing rapid relief of itching within 30 minutes) and stabilizes mast cell membranes, inhibiting histamine, tryptase, and leukotriene degranulation. Indicated for the treatment of signs and symptoms of allergic conjunctivitis (seasonal and perennial).
Polyethylene Glycol 400- 0.4% w/v + Propylene Glycol 0.3% w/v Ophthalmic solution
Demulcent Ocular Lubricant and Artificial Tear formulation on the WHO Model List of Essential Medicines. Forms a viscoelastic, transparent, bioadhesive lubricating polymer shield over the cornea and conjunctiva, stabilizing the pre-corneal tear film, mimicking mucin layer adherence, and protecting the ocular surface against desiccating environmental stress and shear forces during blinking. Indicated for temporary relief of burning, irritation, and discomfort due to dry eye syndrome (keratoconjunctivitis sicca), digital eye strain, wind, or sun exposure.
Travoprost 40mcg + Timolol 5mg Eye Drops
Travoprost (0.004% w/v, alone or with Timolol 0.5%) is a synthetic prostaglandin F2-alpha analogue and full selective FP prostanoid receptor agonist on the WHO Model List of Essential Medicines. It significantly enhances uveoscleral aqueous outflow. Indicated for lowering intraocular pressure in open-angle glaucoma and ocular hypertension.
Betamethasone Sodium Phosphate 0.1% w/v + Neomycin Sulphate 0.5% w/v Eye/Ear Drops
Ceruminolytic Ear Drop formulation combining Paradichlorobenzene (2%), Chlorbutol (5%), Turpentine Oil (15%), and Lidocaine (2%). Paradichlorobenzene hydrates and dissolves hard impacted cerumen; turpentine oil acts as a counter-irritant and cerumen liquefier; chlorbutol provides mild antibacterial and antifungal preservation; and lidocaine relieves localized ear canal pain and tension. Indicated for softening, loosening, and removal of hardened, impacted ear wax.
Betamethasone Sodium Phosphate 0.1% w/v + Ofloxacin 0.3% w/v Eye/Ear Drops
Ceruminolytic Ear Drop formulation combining Paradichlorobenzene (2%), Chlorbutol (5%), Turpentine Oil (15%), and Lidocaine (2%). Paradichlorobenzene hydrates and dissolves hard impacted cerumen; turpentine oil acts as a counter-irritant and cerumen liquefier; chlorbutol provides mild antibacterial and antifungal preservation; and lidocaine relieves localized ear canal pain and tension. Indicated for softening, loosening, and removal of hardened, impacted ear wax.
Latanoprost 50mcg + Timolol Maleate 5mg Opthalmic solution
Latanoprost and Timolol Maleate ophthalmic solution is a fixed-combination ocular hypotensive therapy. Latanoprost (0.005%), a prostaglandin F2-alpha analogue, increases uveoscleral outflow of aqueous humor, while timolol (0.5%), a non-selective beta-adrenergic blocker, reduces aqueous humor production in the ciliary processes. Combining these two complementary mechanisms achieves substantial, sustained intraocular pressure (IOP) reduction. Indicated for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical monotherapy.
Tobramycin 0.3% w/v + Fluoromethalone 0.1% w/v Opthalmic Solution
Tobramycin and Fluorometholone ophthalmic suspension is an antibacterial and surface-selective corticosteroid combination. Tobramycin (0.3%) provides bactericidal coverage against Gram-negative ocular bacilli including Pseudomonas aeruginosa, while fluorometholone (0.1%) delivers targeted corneal and conjunctival anti-inflammatory action with significantly lower intraocular pressure elevation than dexamethasone. Indicated for steroid-responsive inflammatory ocular conditions with secondary bacterial infection risk.
Pilocarpine Tablets 5mg
Pilocarpine Hydrochloride (5 mg tablets) is an oral direct-acting muscarinic cholinergic agonist. It stimulates muscarinic M3 receptors on exocrine glands, dramatically stimulating salivary and lacrimal secretion. Indicated for the treatment of severe xerostomia (dry mouth) caused by radiotherapy for head and neck cancer, and dry mouth/eyes associated with Sjogren's syndrome.
Latanoprost Eye Drops 0.005% w/v (50mcg per ml)
Latanoprost (0.005% w/v) is a synthetic prostaglandin F2-alpha isopropyl ester prodrug on the WHO Model List of Essential Medicines. Following corneal penetration, it is hydrolyzed by corneal esterases to active latanoprost acid, a selective prostanoid FP receptor agonist that remodels the extracellular matrix of the ciliary muscle, dramatically enhancing uveoscleral aqueous humor outflow without altering aqueous production. Indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension.
Statutory Medical Guidance
All products listed are official PMBI-procured generic drugs. Schedule H formulations require a valid physician's prescription for dispensing at Jan Aushadhi Kendras. Never alter prescribed therapies without speaking with your doctor.